You're reading the free version. Trader adds the live tape and alerts.
Start tracking
UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Nov 9, 2026
Sale
Calculated transaction value
$1M
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Nov 6, 2026
Public filing date
Nov 9, 2026
Filing lag
Filed 3 days later
UTHR daily price context
Close on/before transaction
$562.02
Nov 6, 2026
First close after public filing
$588.61
Nov 10, 2026
Return after filing · so far
+1.2%
Through Nov 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,776 shares @ $564.99
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000183
Filing cohort
Transactions in this filing
Showing 11 of 11
Trades
11
Issuers
1
Estimated value
$6.48M
Buys / sales
0 / 9
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Nov 6, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Sale | Nov 6, 2026 | $578.73K |
| United Therapeutics Corp UTHR | Sale | Nov 6, 2026 | $639.42K |
| United Therapeutics Corp UTHR | Sale | Nov 6, 2026 | $1.13M |
| United Therapeutics Corp UTHR | Sale | Nov 6, 2026 | $985.71K |
| United Therapeutics Corp UTHR | Sale | Nov 6, 2026 | $45.49K |
| United Therapeutics Corp UTHR | Exercise | Nov 6, 2026 | $0 |
| United Therapeutics Corp UTHR | Sale | Nov 6, 2026 | $61.13K |
| United Therapeutics Corp UTHR | Sale | Nov 6, 2026 | $490.55K |
| United Therapeutics Corp UTHR | Sale | Nov 6, 2026 | $431.97K |
| United Therapeutics Corp UTHR Current | Sale | Nov 6, 2026 | $1M |